封面
市場調查報告書
商品編碼
2052969

免疫組織化學市場:按產品、應用、最終用戶和地區分類

Immunohistochemistry Market, By Product, By Application, By End User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 142 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計到 2026 年,免疫組織化學 (IHC) 市場規模將達到 32.8 億美元,到 2033 年將達到 52.4 億美元。預計從 2026 年到 2033 年,其複合年成長率將達到 6.9%。

報告範圍 報告詳情
基準年: 2025 2026年市場規模: 32.8億美元
歷史數據時期: 2020-2024 預測期: 2026-2033
2026年至2033年預測期間的複合年成長率: 6.90% 2033年市場規模預測: 52.4億美元

免疫組織化學(IHC)是一種利用抗體特異性結合生物組織內抗原的原理,檢測組織切片中細胞內抗原的技術。 IHC 使研究人員能夠識別正常和病變組織中的細胞類型、生物標記位置以及目標抗原的分佈。這有助於疾病診斷、預後評估以及預測性和個人化醫療。 IHC 利用抗體與抗原之間的親和性,在顯微鏡下觀察組織樣本中細胞內的特定蛋白質,從而輔助細胞類型鑑定和生物分子定位。嚴格控制所用細胞、抗原和抗體對於獲得準確且可重複的結果至關重要。

市場動態

全球免疫組織化學市場的主要驅動力是老年人口的成長以及由此導致的慢性病和感染疾病盛行率的上升。世界衛生組織(WHO)2022年10月發布的報告顯示,預計2015年至2050年間,全球60歲及以上人口的比例將從12%成長至22%,幾乎翻倍。全球癌症發生率的上升也推動了對用於檢測癌症診斷和預後相關生物標記的免疫組織化學檢測的需求。然而,免疫組織化學診斷試劑盒核准的嚴格法規結構以及熟練人員的短缺,尤其是在開發中國家,阻礙了市場成長。數位病理解決方案的出現,例如能夠自動定量分析免疫組織化學染色結果以及整合人工智慧(AI)以實現更精確的分析,為市場相關人員帶來了充滿希望的機會。

本研究的關鍵特徵

  • 本研究確定了各細分市場的潛在收入成長機會,並說明了該市場具有吸引力的投資提案矩陣。
  • 此外,本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
  • 本研究根據以下參數對全球免疫組織化學市場的主要參與者進行了分析:公司亮點、產品系列、關鍵亮點、財務表現和策略。
  • 透過利用本報告中的見解,企業行銷負責人和經營團隊將能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
  • 全球免疫組織化學市場報告的目標受群眾外包括該行業的各類相關人員,例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
  • 相關人員可以透過分析全球免疫組織化學市場中使用的各種策略矩陣輕鬆做出決策。

目錄

第1章:研究目標與前提條件

  • 分析目的
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要
  • 一致性機會圖(COM)

第3章:市場動態、監管與趨勢分析

  • 市場動態
    • 促進因素
    • 抑制因子
    • 市場機遇
  • 影響分析
  • 管道分析
  • PEST分析
  • 監管趨勢
  • 市場趨勢
  • 併購

第4章 全球免疫組織化學市場:依產品類型分類,2021-2033年

  • 抗體
  • 試劑
  • 裝置
  • 成套工具

第5章 全球免疫組織化學市場:依應用領域分類,2021-2033年

  • 診斷
  • 研究
  • 其他

第6章 全球免疫組織化學市場:依最終用戶分類,2021-2033年

  • 醫院
  • 診斷實驗室
  • 學術研究機構
  • 其他

第7章 全球免疫組織化學市場:依地區分類,2021-2033年

  • 北美洲
    • 美國
    • 加拿大
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他拉丁美洲國家
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 韓國
    • ASEAN
    • 其他亞太國家
  • 中東
    • GCC
    • 以色列
    • 其他中東國家
  • 非洲
    • 南非
    • 中非
    • 北非

第8章 競爭情勢

  • 熱圖分析
  • 市佔率分析
    • Merck KGaA
    • Rockland Immunochemical, Inc.
    • F. Hoffman-La Roche Ltd.
    • Thermo Fisher Scientific
    • PerkinElmer, Inc.
    • Bio-Rad Laboratories, Inc.
    • Cell Signaling Technology, Inc.
    • Bio SB
    • Agilent Technologies, Inc.
    • Abcam plc.
    • Bectom, Dickson and Company
    • Miltenyi BIoTec
    • Biocare Medical, LLC
    • Eagle Bioscience, Inc.
    • Bio Techne
    • Diagnostic Biosystems, Inc.
    • BioGenex

第9章 分析師觀點

  • 機會分析
  • 分析師意見
  • 一致的機會地圖

第10章:參考文獻與調查方法

  • 參考
  • 調查方法
簡介目錄
Product Code: CMI4795

Immunohistochemistry Market is estimated to be valued at USD 3.28 Bn in 2026 and is expected to reach USD 5.24 Bn by 2033, growing at a compound annual growth rate (CAGR) of 6.9% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 3.28 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 6.90% 2033 Value Projection: USD 5.24 Bn

Immunohistochemistry (IHC) is a technique used to detect antigens in cells of a tissue section by exploiting the principle of antibodies binding specifically to antigens in biological tissues. IHC enables researchers to identify cell types and locations of biomarkers as well as the distribution of target antigens in normal and diseased tissues. It helps in disease diagnosis, prognostic evaluation, and predictive and personalized medicine. IHC uses affinity between antibodies and antigens for making specific proteins in cells of a tissue sample visible microscopically, thus aiding in the identification of cell type and localization of biomolecules. The cells, antigens, and antibodies used must be carefully controlled to ensure accurate and reproducible results.

Market Dynamics

The global immunohistochemistry market is primarily driven by the rising geriatric population and associated increase in prevalence of chronic and infectious diseases. According to the World Health Organization (WHO) October 2022 report, the proportion of the world's population over 60 years will nearly double from 12% to 22% between 2015 and 2050. The growing incidence of cancer worldwide is also boosting the demand for IHC assays to detect biomarkers related to cancer diagnosis and prognosis. However, stringent regulatory frameworks for the approval of IHC diagnostic kits and lack of skilled personnel especially in developing nations are some challenges restraining the market growth. The emergence of digital pathology solutions offering automated quantification of IHC staining and integration of Artificial Intelligence for more accurate analysis present lucrative opportunities for market players.

Key Features of the Study

  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global immunohistochemistry market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include Merck KGaA, Rockland Immunochemicals Inc., F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific, PerkinElmer Inc., Bio-Rad Laboratories Inc., Cell Signaling Technology Inc., Bio SB, Agilent Technologies Inc., Abcam plc., Becton Dickinson and Company, Miltenyi Biotec, Biocare Medical LLC, Eagle Biosciences Inc., Bio-Techne, Diagnostic Biosystems Inc., and BioGenex.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global immunohistochemistry market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global immunohistochemistry market.

Market Segmentation

  • Product Insights (Revenue, USD Bn, 2021 - 2033)
  • Antibodies
    • Primary Antibodies
    • Secondary Antibodies
  • Reagents
    • Proteolytic Enzymes
    • Fixation Reagents
    • Histological Stains
    • Diluents
    • Others
  • Equipment
    • Slide-staining systems
    • Tissue Processing Systems
    • Slide Scanners
    • Other Equipment
  • Kits
  • Application Insights (Revenue, USD Bn, 2021 - 2033)
  • Diagnostics
    • Cancer
    • Infectious Diseases
    • Autoimmune Diseases
    • Neurological Diseases
    • Others Diseases
  • Research
  • Others
  • End User Insights (Revenue, USD Bn, 2021 - 2033)
  • Hospitals
  • Diagnostics Laboratories
  • Academic & Research Institutes
  • Others
  • Regional Insights (Revenue, USD Bn, 2021 - 2033)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
  • Merck KGaA
  • Rockland Immunochemicals Inc.
  • F. Hoffmann-La Roche Ltd.
  • Thermo Fisher Scientific
  • PerkinElmer Inc.
  • Bio-Rad Laboratories Inc.
  • Cell Signaling Technology Inc.
  • Bio SB
  • Agilent Technologies Inc.
  • Abcam plc.
  • Becton Dickinson and Company
  • Miltenyi Biotec
  • Biocare Medical LLC
  • Eagle Biosciences Inc.
  • Bio-Techne
  • Diagnostic Biosystems Inc.
  • BioGenex.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Product
    • Market Snippet, By Application
    • Market Snippet, By End User
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Pipeline Analysis
  • PEST Analysis
  • Regulatory Scenario
  • Market Trends
  • Key Highlights
  • Mergers & Acquisitions

4. Global Immunohistochemistry Market, By Product Type, 2021 - 2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Antibodies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
      • Primary Antibodies
      • Secondary Antibodies
  • Reagents
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
      • Proteolytic Enzymes
      • Fixation Reagents
      • Histological Stains
      • Diluents
      • Others
  • Equipment
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
      • Slide-staining systems
      • Tissue Processing Systems
      • Slide Scanners
      • Other Equipment
  • Kits
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

5. Global Immunohistochemistry Market, By Application, 2021 - 2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Diagnostics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
      • Cancer
      • Infectious Diseases
      • Autoimmune Diseases
      • Neurological Diseases
      • Others Diseases
  • Research
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

6. Global Immunohistochemistry Market, By End User, 2021 - 2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Diagnostic Laboratories
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Academic & Research Institutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

7. Global Immunohistochemistry Market, By Region, 2021 - 2033, (USD Bn)

  • Introduction
    • Market Share Analysis, By Region, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, For Regions, 2021-2033
  • North America
    • Market Size and Forecast, By Product Type, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, By Application, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, By End User, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, By Country, 2021 - 2033, (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Market Size and Forecast, By Product Type, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, By Application, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, By End User, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, By Country, 2021 - 2033, (USD Bn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Market Size and Forecast, By Product Type, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, By Application, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, By End User, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, By Country, 2021 - 2033, (USD Bn)
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Product Type, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, By Application, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, By End User, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, By Country, 2021 - 2033, (USD Bn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Market Size and Forecast, By Product Type, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, By Application, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, By End User, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, By Country, 2021 - 2033, (USD Bn)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Market Size and Forecast, By Product Type, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, By Application, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, By End User, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, By Country/Region, 2021 - 2033, (USD Bn)
      • South Africa
      • Central Africa
      • North Africa

8. Competitive Landscape

  • Heat Map Analysis
  • Market Share Analysis
    • Merck KGaA
      • Company Overview
      • Product Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • Rockland Immunochemical, Inc.
      • Company Overview
      • Product Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • F. Hoffman-La Roche Ltd.
      • Company Overview
      • Product Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • Thermo Fisher Scientific
      • Company Overview
      • Product Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • PerkinElmer, Inc.
      • Company Overview
      • Product Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • Bio-Rad Laboratories, Inc.
      • Company Overview
      • Product Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • Cell Signaling Technology, Inc.
      • Company Overview
      • Product Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • Bio SB
      • Company Overview
      • Product Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • Agilent Technologies, Inc.
      • Company Overview
      • Product Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • Abcam plc.
      • Company Overview
      • Product Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • Bectom, Dickson and Company
      • Company Overview
      • Product Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • Miltenyi Biotec
      • Company Overview
      • Product Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • Biocare Medical, LLC
      • Company Overview
      • Product Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • Eagle Bioscience, Inc.
      • Company Overview
      • Product Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • Bio Techne
      • Company Overview
      • Product Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • Diagnostic Biosystems, Inc.
      • Company Overview
      • Product Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • BioGenex
      • Company Overview
      • Product Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies

9. Analyst View

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

10. References and Research Methodology

  • References
  • Research Methodology
  • About us and Sales Contact